🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This will be devastating for cancer research.

NIH Grants Fueled $95 Billion In FY 2024 Economic Activity, Finds New Report forbes.com/sites/michaelt…

In fiscal year 2024, NIH grants supporting more than 408,000 jobs and generating over $94.5 billion in new economic activity nationwide. The grants also save countless lives, #NIH #researchfundings news.harvard.edu/gazette/story/…

ANNOUNCEMENT: RFA for 2025 Prostate Cancer Foundation team science Challenge Award Applications, to support investigations of metastatic, lethal #ProstateCancer in 6 specified topic areas. DEADLINE: May 5, 2025 Apply at: pcf.smartsimple.com View the RFA: res.cloudinary.com/pcf/images/v17…

Ranju Batra & I🇺🇸were delighted to celebrate the amazing Ash Tewari, MD of Mount Sinai Health System, led by Brendan G. Carr, MD, MA, MS, with dear Amb. Binaya Pradhan🇮🇳India in New York, and applaud the great prostate cancer research conducted under the empathetic leadership of dear Ash! Congratulations

We look forward to hearing from N.V. Kishore Pillarsetty, PhD, on May 6. "Novel Radiotheranostics for Prostate and Bladder Cancer" The Pillarsetty Lab @ MSK Hosted by Goutam Chakraborty #prostatecancer #bladdercancer

Exiting moment for #chakrabortylab members Icahn School of Medicine at Mount Sinai Mount Sinai Department of Urology The Tisch Cancer Institute for 1st AACR annual meeting. Join us in the poster session to learn our research on #prostatecancer, Poster 5104: Prathiksha ; 6728 Sarah ; 7469 Nabila. #AACR25 Prostate Cancer Foundation

NIH to prioritize human-based research technologies | National Institutes of Health (NIH) nih.gov/news-events/ne…

Congratulations to #chakrabortylab postdoctoral fellow Prathiksha for her presentation in #AACR25. Exciting discussion and brainstorming in the poster session, such a wonderful experience for early career scientists #proudPI The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai Mount Sinai Department of Urology Prostate Cancer Foundation

What we know about the prostate cancer undetectable by PSA test, and the biology behind it. Outstanding presentation by #chakrabortylab researcher Nabila on Low -PSA prostate cancer, from clinic to Biology #AACR25 Mount Sinai Department of Urology The Tisch Cancer Institute Ash Tewari, MD #invisibleprostatecancer

How sex chromosomes affects cancer is an unsolved question. #chakrabortylab Postdoc and recipient of #AACR25 minority research scholar award Sarah investigating Y chromosome in cancer. Truly exciting scientific quest Mount Sinai Department of Urology The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai #ProstateCancer

Outside Science, what i like to do most #photograghy #hobby #nikon #readyforaphotoshoot #lovephotography

Today, the American Association for Cancer Research (AACR) called on Congress to reject the Administration's nearly 40% cut to the NIH budget and allocate a bipartisan funding increase to $51.3 billion for the agency to accelerate progress for patients. brnw.ch/21wSrQk

Congratulations Class of 2024

.Ash Tewari, MD discusses former President Joe Biden's prostate cancer diagnosis. livenowfox.com/video/1643349 #prostatecancer Mount Sinai Department of Urology Icahn School of Medicine at Mount Sinai

Prostate cancer Q&A - YouTube youtube.com/watch?v=wPQBdc…

Is Biden's Diagnosis A Wake-Up Call? youtube.com/shorts/Y12rDeC… via YouTube With Ash Tewari, MD Mount Sinai Department of Urology Icahn School of Medicine at Mount Sinai #prostatecancer

Ab#5019 ASCO #ASCO25 by #StefanieZschaebitz 👉bit.ly/3H1usYW👉Exploratory analysis of ph3 TALAPRO-2 trial in pts w/ mCRPC #prostatecancer👉Benefit w/ talazoparib + enzalutamide across multiple HRR gene subgroups👇@huntsman_GU OncoAlert UroToday.com PCF Science

Ab#5094 ASCO #ASCO25 by David Olmos👉bit.ly/4kqzTPe👉Impact of BRCA and HRR alt in pts w/ mHSPC #prostatecancer 👉Pts w/ BRCA alt have worse survival regardless of disease volume or treatment received👇Elena Castro OncoAlert UroToday.com PCF Science

In just recent years, U.S. science cured MSI+ metastatic cancers, cured hepatitis C, turned untreatable diseases like cystic fibrosis, multiple sclerosis, sickle cell disease, hemophilia, congenital blindness, and several metabolic disorders—into treatable conditions.